Doctor Concerned About Canadian Human Trials of Virus Vaccine Developed in Partnership With Chinese Military

A child receives a vaccination shot at a hospital in Rongan in China's southern Guangxi region on July 23, 2018. That year, a scandal rocked China after a Chinese company was found to have shipped more than 250,000 doses of a faulty DTaP vaccine, affecting more than 200,000 children. (AFP via Getty Images)

A medical doctor is expressing concern about Canadians receiving an experimental COVID-19 vaccine developed with the help of the Chinese military.

Canada’s National Research Council (NRC) announced a collaboration initiative with the Chinese company CanSino Biologics Inc. on the clinical development of the company’s new AD5-nCoV vaccine, Ad5-nCoV. CanSino developed the vaccine in partnership with China’s military.

Health Canada has approved the first human clinical trials that will run at the Canadian Centre for Vaccinology at Dalhousie University.  The company is already conducting human clinical trials for the vaccine in China.

Dr. Kulvinder Gill, a medical doctor based in the Toronto area and president of Concerned Ontario Doctors, says she’s worried about Canadians becoming human subjects of a vaccine developed in China.

“Canada is literally the only country in the entire world offering up its own citizens as guinea pigs in this unethical, rapid, human clinical trial of the Chinese SARS-CoV-2 vaccine—in partnership with the communist Chinese military that is already under a cloud of global suspicion,” Gill says.

SARS-CoV-2 v is the scientific name of the Chinese Communist Party (CCP) virus, also known as the novel coronavirus, which causes COVID-19.

The Canadian government is spending $44 million to upgrade NRC’s Montreal facilities to enable mass production of a vaccine for COVID-19. The NRC has been working with CanSino since 2013.

Gill says the process for developing a vaccine shouldn’t be rushed, citing comments from Dr. Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases.

“I must warn that there is also the possibility of negative consequences where certain vaccines can actually enhance the negative effect of the infection,” Fauci said recently.

Gill says the process for developing vaccines normally takes years.

“This human clinical trial with China’s Communist Party vaccine is proceeding at an alarming rate,” she says. “The typical vaccine development cycle is approximately 10 to 15 years. The shortest vaccine development cycle on record is actually four years, and that was for the mumps vaccine.”

Gill also notes that China has a bad record when it comes to vaccines. She says there have been several major vaccine scandals in China in recent years, including in 2018 when hundreds of thousands of children were injected with faulty vaccines.

“Most colleagues and other Canadians that I have spoken to have said that they want nothing to do with a vaccine if there’s any affiliation with the Chinese Communist Party because there’s such lack of trust in overall handling of the epidemic to date,” she says.

As reported by The Epoch Times, the Chinese regime hid information about the human-to-human transmission of the CCP virus for at least several days, and reprimanded whistleblowers who tried to warn others about the virus.

The NRC was subjected to intense cyberattacks by Chinese state-sponsored hackers in 2014, costing hundreds of millions of dollars in damages.

Gill believes that legitimate informed consent would include telling participants of the CCP’s involvement in the vaccine. However, she would prefer that the partnership be dropped altogether.

“It’s fundamental for our government to abandon this dangerous endeavour and instead ... fund vaccine trials with our allied nations who understand the importance of trust and ethics and transparency.”

The Epoch Times reached out to the NRC and Health Canada but no comments were received by press time.

A spokesperson for the Canadian Center for Vaccinology said, “We are still waiting for final approval and will be in touch soon to give you detailed study information.”